Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 1777-1783

  Kupferman, Michael E ^a,c   Fini, M Elizabeth ^a   Muller, William J ^b   Weber, Randal ^c   Cheng, Yi ^a   Muschel, Ruth J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BETA GALACTOSIDASE; GELATINASE B; PHORBOL 12 ACETATE 13 MYRISTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEWBORN; NONHUMAN; PELVIS CANCER; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SKIN CARCINOGENESIS; TERATOMA; TRANSGENIC MOUSE;

EID: 0033637209     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64815-8     Document Type: Article

References (50)

1. Mammary gland neoplasia: Insights from transgenic mouse models
2. Histopathology of transgenic mouse mammary tumors (a short atlas)
3. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease
4. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes
5. Matrix metalloproteinases
6. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion
7. Biosynthesis of alpha2(IV) and alpha 1(IV) chains of collagen IV and interactions with matrix metalloproteinase-9
8. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system
9. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma
10. Regulation of matrix metalloproteinase gene expression
11. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
12. Murine matrix metalloproteinase 9 gene. 5'-upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice
13. The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription
14. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements: A mechanism regulating gene expression independent of that by inflammatory cytokines
15. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements
16. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
17. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat
18. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line
19. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
20. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B
21. Gelatinase B/lacZ transgenic mice, a model for mapping gelatinase B expression during developmental and injury-related tissue remodeling
22. FVB/N mice: An inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin
23. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization
24. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization
25. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
26. Metalloproteinases and their inhibitors in squamous cell carcinoma of the hypopharynx: Indicators of individual tumor aggressiveness
27. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential
28. Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines
29. Fibroblast-directed expression and localization of 92kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma
30. 'Proteolytic switching': Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
31. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas
32. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas
33. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer
34. Different expression patterns of MMP-2 and MMP-9 in breast cancer
35. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression
36. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
37. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization
38. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: Clinico-pathological correlations
39. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells
40. Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness
41. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloproteinase-9
42. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes
43. c-fos is required for malignant progression of skin tumors
44. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
45. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice
46. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas
47. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
48. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma
49. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression
50. Defective trophoblast function in mice with a targeted mutation of Ets2